The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.
about
A new 2α,5α,10β,14β-tetraacetoxy-4(20),11-taxadiene (SIA) derivative overcomes paclitaxel resistance by inhibiting MAPK signaling and increasing paclitaxel accumulation in breast cancer cellsNovobiocin, a Newly Found TRPV1 Inhibitor, Attenuates the Expression of TRPV1 in Rat Intestine and Intestinal Epithelial Cell Line IEC-6
P2860
The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@en
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@nl
type
label
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@en
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@nl
prefLabel
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@en
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@nl
P2093
P2860
P1476
The elimination of MTC-220, a ...... l dipeptide analogue, in rats.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-013-2144-7
P577
2013-04-05T00:00:00Z